Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, June 16, 2023
[ Fri, Jun 16th 2023
] - WOPRAI
[ Fri, Jun 16th 2023
] - WOPRAI
[ Fri, Jun 16th 2023
] - WOPRAI
[ Fri, Jun 16th 2023
] - WOPRAI
[ Fri, Jun 16th 2023
] - WOPRAI
[ Fri, Jun 16th 2023
] - WOPRAI
[ Fri, Jun 16th 2023
] - WOPRAI
[ Fri, Jun 16th 2023
] - WOPRAI
[ Fri, Jun 16th 2023
] - WOPRAI
[ Fri, Jun 16th 2023
] - WOPRAI
[ Fri, Jun 16th 2023
] - WOPRAI
[ Fri, Jun 16th 2023
] - WOPRAI
[ Fri, Jun 16th 2023
] - WOPRAI
[ Fri, Jun 16th 2023
] - WOPRAI
[ Fri, Jun 16th 2023
] - WOPRAI
[ Fri, Jun 16th 2023
] - WOPRAI
[ Fri, Jun 16th 2023
] - WOPRAI
[ Fri, Jun 16th 2023
] - WOPRAI
[ Fri, Jun 16th 2023
] - WOPRAI
[ Fri, Jun 16th 2023
] - WOPRAI
[ Fri, Jun 16th 2023
] - WOPRAI
Thu, June 15, 2023
[ Thu, Jun 15th 2023
] - WOPRAI
[ Thu, Jun 15th 2023
] - WOPRAI
[ Thu, Jun 15th 2023
] - WOPRAI
[ Thu, Jun 15th 2023
] - WOPRAI
[ Thu, Jun 15th 2023
] - WOPRAI
[ Thu, Jun 15th 2023
] - WOPRAI
Frank Takkinen Maintained (APYX) at Strong Buy with Increased Target to $9 on, Jun 15th, 2023
Frank Takkinen of Lake Street, Maintained "Apyx Medical Corporation" (APYX) at Strong Buy with Increased Target from $6 to $9 on, Jun 15th, 2023.
Frank has made no other calls on APYX in the last 4 months.
There is 1 other peer that has a rating on APYX. Out of the 1 peers that are also analyzing APYX, all agrees with Frank's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- David Turkaly of "JMP Securities" Reiterated at Hold on, Wednesday, May 24th, 2023
